This fellowship consists of one to two years of mentored research in basic or translational science or outcomes research and one year in clinical urologic oncology.
During the research portion of the fellowship, the fellow engages in a focused area of study in prostate, kidney or bladder cancer with an investigator in Cleveland Clinic’s Lerner Research Institute or an outcomes researcher in the Department of Quantitative Health Sciences. Specific training in clinical trial design and biostatistics also is provided during the research portion of the fellowship.
The clinical portion of the fellowship will consist of rotations with the oncology and minimally invasive surgical staff. The clinical program is designed to provide fellows with a practical knowledge of the most up-to-date methods of diagnosing and treating urologic cancers. The responsibilities for clinical care are shared by the faculty, fellows, residents and physician assistants in the operating room, in the clinic and on the ward. The volume and nature of the clinical experience is such that the fellow has an opportunity to participate in the management of patients with all types and stages of urologic cancer. A strong emphasis on complex urological procedures and minimally invasive surgery is provided. To receive multidisciplinary oncology training, a rotation in medical oncology and radiation oncology also is provided.
Formal educational sessions include a weekly didactic lecture series that covers all areas of genitourinary oncology, multidisciplinary genitourinary oncology tumor board, monthly genitourinary oncology grand rounds and monthly oncology journal club.
This fellowship is recognized by the Society of Urologic Oncology (SUO) and fellows are eligible to apply for membership in the SUO upon completion of the fellowship program.
Regularly performed procedures
- Robotic, open and laparoscopic partial nephrectomy
- Robotic, open and laparoscopic radical nephrectomy
- Robotic, open and laparoscopic nephrouretetectomy
- Open and robotic radical prostatectomy
- Robotic and open radical cystectomy
- Continent and non-continent urinary diversion
- Primary and post-chemotherapy
- retroperitoneal lymph node dissection
- Ryan Berglund, MD
- Steven Campbell, MD
- Amr Fergany, MD
- Michael Gong, MD
- Georges-Pascal Haber, MD, PhD
- Jihad Kaouk, MD
- Eric Klein, MD
- Venkatesh Krishnamurthi, MD
- Andrew Stephenson, MD
- James Ulchaker, MD
Lerner Research Institute
Quantitative Health Services
How to apply
This program participates in the Society of Urologic Oncology MATCH Program.
Andrew J. Stephenson, MD
Director, Center for Urologic Oncology
Fellowship Program Director, Urologic Oncology
Cleveland Clinic Glickman Urological & Kidney Institute
9500 Euclid Ave., Q10-1
Cleveland, OH 44195